- Home
- DTIL vs FBIO Comparison
DTIL vs FBIO Comparison
Compare DTIL & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTIL
- FBIO
- Stock Information
- Founded
- DTIL 2006
- FBIO 2006
- Country
- DTIL United States
- FBIO United States
- Employees
- DTIL N/A
- FBIO N/A
- Industry
- DTIL Biotechnology: Pharmaceutical Preparations
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- DTIL Health Care
- FBIO Health Care
- Exchange
- DTIL Nasdaq
- FBIO Nasdaq
- Market Cap
- DTIL 51.6M
- FBIO 49.1M
- IPO Year
- DTIL 2019
- FBIO N/A
- Fundamental
- Price
- DTIL $4.83
- FBIO $1.89
- Analyst Decision
- DTIL Strong Buy
- FBIO Strong Buy
- Analyst Count
- DTIL 2
- FBIO 3
- Target Price
- DTIL $47.00
- FBIO $21.00
- AVG Volume (30 Days)
- DTIL 74.8K
- FBIO 178.7K
- Earning Date
- DTIL 05-15-2025
- FBIO 05-15-2025
- Dividend Yield
- DTIL N/A
- FBIO N/A
- EPS Growth
- DTIL N/A
- FBIO N/A
- EPS
- DTIL N/A
- FBIO N/A
- Revenue
- DTIL $51,141,000.00
- FBIO $57,784,000.00
- Revenue This Year
- DTIL N/A
- FBIO $63.20
- Revenue Next Year
- DTIL $30.20
- FBIO $66.70
- P/E Ratio
- DTIL N/A
- FBIO N/A
- Revenue Growth
- DTIL N/A
- FBIO N/A
- 52 Week Low
- DTIL $3.61
- FBIO $1.33
- 52 Week High
- DTIL $13.32
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- DTIL 46.95
- FBIO 60.90
- Support Level
- DTIL $4.51
- FBIO $1.66
- Resistance Level
- DTIL $5.10
- FBIO $1.96
- Average True Range (ATR)
- DTIL 0.27
- FBIO 0.11
- MACD
- DTIL -0.00
- FBIO 0.02
- Stochastic Oscillator
- DTIL 40.00
- FBIO 80.56
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.